OncologyEducation is proud to feature Dr. Caroline Robert discussing the Management of Melanoma Patients in the Metastatic Setting.
This live educational program will be offered in Toronto, ON and Montréal, QC (delivered in French).

Note: This program is for healthcare professionals only.


Learning Objectives:

  1. Management of patients with metastatic melanoma in terms of treatment strategy and adverse events.
  2. Mechanisms of resistance.
  3. Potential predictive biomarkers and future directions.

Target Audience: 

Medical oncologists, pharmacists, nurses treating melanoma patients. 


Live Dinner Presentations and Sessions

Toronto - Wednesday April 18, 2018

Local Chair: Dr. Teresa Petrella

Morton's (Private Room A)
4 Avenue Road
Toronto, ON

6:30 PM - Arrivals
7:00 PM - Dinner & Presentation

Live event for the Toronto venue is sold out.
Space still available for the webinar. See below for more details. 


Montreal - Thursday, April 19, 2018
** Note: This presentation will be delivered in French

Présidée par Dr Catalin Mihalcioiu

Ferreria Café
1446, rue Peel
Montréal (Québec)
Salle privée

18 h 30 - Arrivée
19 h - Souper et présentation


Webinar Presentations

English April 18, 2018 7PM EDT


French
April 19, 2018 7PM EDT


About the Speaker: 

Dr Marc Peeters

Dr. Caroline Robert, M.D., Ph.D.

Dr. Robert is the Head of the Dermatology Service at Gustave Roussy Cancer Campus and co-director of the Melanoma Research Unit at INSERM 981 Paris-Sud University. She trained at the Paris V University, France and completed a research fellowship at Harvard, Brigham & Women's hospital in Cancer Immunology and Immunotherapy. She chairs the Melanoma group of the European Organization for the Research and Treatment of Cancer (EORTC) and is board member for the European Association of Onco-Dermatology (EADO), the European Society of Medical Oncology (ESMO), the European Association of Dermato-Venereology (EADV) the French society of Dermatology and Venereology (SFD), the American Society of Oncology (ASCO) and the American Association of Clinical Research (AACR). Her main focuses of interest are clinical and translational Research on Melanoma: immunotherapy and targeted therapy, as well as the study of the cutaneous adverse events of anticancer agents. She is national and international coordinator of many clinical trials of targeted therapy and immunotherapy for melanoma patients, from phase I to III. She has authored more than 240 articles in peer-reviewed scientific journals, including a number of publications on new treatments for metastatic melanoma

Her recent work has focused on identification of new biomarkers for immunotherapy and targeted therapies of patients with melanoma.


This program was made possible by the unrestricted sponsorship support from Merck. 


Other Information

For more information, please send requests to  andrea@oncologyeducation.com.

Oncology Clinical News

Surgery May Benefit Some With Early Prostate Cancer: Study

(U.S. News & World Report/HealthDay News) Dec 12, 2018 - For certain men with early prostate cancer, choosing surgery over "watchful waiting" may add a few years to their lives, a new study suggests. European researchers found that among nearly 700 men with earlier-stage prostate cancer, those who received surgery to remove the gland lived three years longer, on average, than those assigned to watchful waiting. However, experts had major caveats about the study, which followed men who were treated for prostate cancer 20 to 30 years ago.
Read full article.

Fetal Tissue Research Targeted by Abortion Foes Inside Administration


Read full article.

Excess Body Weight Responsible For 4% Of Cancers Worldwide, Study Says

(CNN) Dec 12, 2018 - Excess body weight was responsible for 3.9% of cancer globally, or 544,300 cases, in 2012, according to a new report. The new report also highlights a relationship between obesity and the risk of 13 cancers. "Despite numerous studies on the health effects of overweight/obesity (excess body weight), the message has not been well disseminated. In particular, not many people are aware of the link of overweight/obesity to cancer risk," Hyuna Sung, one of the report's authors and a principal scientist at the American Cancer Society, wrote in an email.
Read full article.

Powered by OBR Oncology